Indications -- Hepatitis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Hepatitis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (62)	4/25/2004 4:09:16 PM
From: zeta1961	Read Replies (3) of 312

Digestive Disease Week and Hepatitis.... HepB abstracts...this list is not necessarily comprehensive...my next post will have a few more that I didn't save in the right format...sunday brain.... _________________________________________________________ p://ddw04.agora.com/planner/displayabstract.asp?presentationid=11377 adefovir resistance mutations emerged at a delayed rate and with low frequency after 144 weeks of adefovir dipivoxil therapy in chronic hepatitis B patients. ddw04.agora.com cost effectiveness of Adefovir Salvage therapy in Chronic Hepatitis B ddw04.agora.com Preclinical of an antisense RNA to a Novel Gene Fg12 in fulminant Viral hepatitis in mice ddw04.agora.com 13C-Caffeine Breath test distinguishing Cirrhosis in chronic HBV ddw04.agora.com epidemiology of chronic HBV in lower Manhattan ddw04.agora.com more Adevofir data ddw04.agora.com serum protemomic profiling predicts liver fibrosis in chronic HBV ?future alternative to liver biopsy? misc:http://ddw04.agora.com/planner/displayabstract.asp?presentationid=3236 less invasive accurate Hpyolori test ddw04.agora.com stool antigen test for H.Pylori ______________________________________________________________________________ Hep C abstracts: ddw04.agora.com Amantadine+IFN/ribavirin ddw04.agora.com improved viral response, adherence and QOL in ifn/ribavirin treated patients who received nursing support ddw04.agora.com ?improved efficacy combining selective granulocyte and monocyte adsorptive apheresis(GMA) with ifn/ribavirin therapy ddw04.agora.com another GMA+ifn/ribavirin study ddw04.agora.com antioxidants don't reduce anemia in ifn/ribvirin patients ddw04.agora.com no advantage with peg-interferon in depression side effects when compared to unpegylated intereron/ribavirin tx ddw04.agora.com ethnic differences in SVR for HCV treated patients ddw04.agora.com older HCV patients experience higher ribavirin associated anemia ddw04.agora.com IFN alfacon+Ribavirin in pegIFN+ribarirn non-respnders ddw04.agora.com Opioid use in chronic HCV patients ddw04.agora.com Epoetin, insurance coverage,efficacy for ifn/ribarin tx ddw04.agora.com viramadine vs. ribavirin in anemia ddw04.agora.com another IFN alfacon(consensus interferon) study in pegIFN+ribavirin nonresponders ddw04.agora.com Anti-Apoptotic Caspase Inhibitor lowers aminotransferases in HCV ddw04.agora.com mistletoe tx for nonresponders ddw04.agora.com preliminary darbepoetin alpha(DA) for ifn/ribavirin patients ddw04.agora.com preliminary data: IFN alfacon-1+IFN gamma 1b in pegintron/ribavirin nonresponders ddw04.agora.com cost effectiveness analysis of growth factors during HCV tx ddw04.agora.com why HCV patients don't attend clinic appts...focused group analysis ddw04.agora.com high prevalence of novel genotypes in Vietnamese patients with HCV ddw04.agora.com hemoglobin decline not associated with SVR in IFN+ribavirin tx patients ddw04.agora.com cost effectiveness of Peg-IFN/ribavirin in relationship to untreated population medical costs and QOL costs ddw04.agora.com Osteoporosis in HCV

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next